AOL Money & Finance

Option Update: Genentech volatility elevated; shares below Roche's $89 offer

Posted Oct 8th 2008 10:15AM by Paul FosterPaul Foster RSS Feed
Filed under: International Business Machines (IBM), Genentech Inc (DNA), Options

More

Genentech (NYSE: DNA) closed at $78.19 Tuesday. Roche announced on July 21 the offer to buy the balance of 44% of DNA it does not own for $89 cash. DNA November option implied volatility of 60 is above its 26-week average of 33 according to Track Data, suggesting larger price movement.

IBM (NYSE: IBM) closed at $95.65 Tuesday. IBM is scheduled to report Q3 EPS on October 16. Thomas Weisel lowered its 12-month price target form $143 to $120. IBM October option implied volatility is at 85, November is at 60; above it's above its 26-week average of 30 according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Tags: dba, genentech, ibm, option implied volatility, OptionImpliedVolatility, roche

Symbol Lookup
IndexesChangePrice
DJIA-52.6010,238.66
NASDAQ-9.002,157.90
S&P 500-6.701,091.81

Last updated: November 12, 2009: 02:20 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines